COR Medical Ventures Company Profile

Background

COR Medical Ventures is a leading medical device development company headquartered in Solana Beach, California. The company is dedicated to advancing healthcare by bringing the next generation of medical devices to market. With an entrepreneurial mindset, COR Medical Ventures partners with individuals, from surgeon inventors to established corporations, to develop innovative medical solutions. The company's expertise spans product development, intellectual property, regulatory affairs, quality system management, prototyping, manufacturing, fundraising, marketing, and business development.

Key Strategic Focus

COR Medical Ventures operates through three primary branches:

1. Consulting Services: Offering comprehensive support from initial concept through design, development, FDA clearance, and market launch.

2. Venture Studio: Partnering with surgeons, clinicians, and inventors to bring their ideas to market by establishing independent companies and accelerating their development through product development consulting services and a network of medical device partners.

3. Distribution Services: Providing logistics and distribution services for early-stage medical device manufacturers, including warehousing, inventory management, order fulfillment, customer support, freight management, and loaner & consignment management.

Financials and Funding

Over the past decade, COR Medical Ventures has raised over $80 million in seed capital to fund its portfolio companies, which are at various stages of development and commercialization.

Pipeline Development

COR Medical Ventures has a diverse portfolio of companies and products in various stages of development:

• Avira Health: Developing next-generation wearable breast pump technology, with a planned launch in the U.S. market.

• Delta Orthopedics: Creating a simple, easy-to-use hinge knee system for treating distal femoral fractures, currently seeking corporate partners or investors to complete 510(k) clearance and initial alpha launch.

• Meduloc: Developing an intermedullary fixation system for small, long-bone fractures, with a design-stable implant and instrument kit, and completed pre-submission FDA meeting.

• Osheru: Introducing Ziplyft, a minimally invasive eyelid surgery procedure, with a clinical launch planned for 2023.

• Osteal Therapeutics: Developing a novel therapeutic platform for treating orthopedic infections, currently in Phase 3 clinical trials.

• Sail Fusion: Creating a robust spinal fixation system for treating Sacro-Iliac joint dysfunction, with 510(k) clearance expected by Q3 2023.

• Sensor Therapeutics: Developing wearable biofeedback and data recording devices for use in rehabilitation following musculoskeletal surgery, currently in early clinical evaluation.

• Spine Innovation: Developing a multi-planar expandable interbody spinal fusion system, currently supporting human clinical cases with 510(k) clearance.

• Tesa Medical: Focusing on improving patient outcomes through enabling rapid, precise soft tissue tensioning and fixation, with a design-stable implant and instruments, and a clearly defined regulatory pathway.

Technological Platform and Innovation

COR Medical Ventures distinguishes itself through its comprehensive approach to medical device development, encompassing:

• Proprietary Technologies: Development of unique medical devices across various specialties, including orthopedic, spine, sports medicine, extremities, women's health, drug delivery, dental, surgical, neurosurgery, maxillofacial, wound care, and plastic surgery.

• Scientific Methodologies: Utilization of in-house expertise in product development, intellectual property, regulatory affairs, quality system management, prototyping, manufacturing, fundraising, marketing, and business development to rapidly innovate and commercialize medical devices.

Leadership Team

• Ben Arnold, MS: Chief Executive Officer

• Brian Bowman, BS: Chief Technology Officer

• Michael Collins, MS, MBA: Chief Operating Officer

• Stephen Spring, BS: Senior Manager, Business Development

• Alyson Ronald, BA, MBA: Director, Operations and Finance

The leadership team brings over 75 years of combined experience in medical devices, with over 100 issued patents and a global reputation for speed and responsiveness.

Competitor Profile

Market Insights and Dynamics

The medical device industry is highly competitive, with numerous companies striving to innovate and capture market share. The market is characterized by rapid technological advancements, stringent regulatory requirements, and significant investment in research and development.

Competitor Analysis

Key competitors in the medical device development sector include:

• Intuitive Surgical: Specializes in robotic-assisted, minimally invasive surgery.

• Olympus: Offers a wide range of medical devices, including endoscopic equipment.

• Boston Scientific: Develops medical solutions across various specialties, including cardiology and neurology.

• ResMed: Focuses on sleep apnea and respiratory care solutions.

• Henry Schein: Provides healthcare products and services to dental and medical practitioners.

• Medline Industries, Inc.: Offers a wide variety of healthcare supply chain solutions.